Hillerød Hospital
Hillerød, 3400, Denmark
NCT Number: NCT01679392
In this study we investigate the following properties of the transversus abdominis plane block in healthy volunteers:
1. Cutaneous analgesic distribution 2. Muscular affection 3. Reproducibility
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hillerød, 3400, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unilateral, single shot, ultrasound-guided, transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)
Other names: Naropin
Time frame: 90 min
Cutaneous analgesic distribution 90 min after transversus abdominis plane block administration
Time frame: 90 min
Abdominal wall muscle affection of the transversus abdominal plane block measured by ultrasonography under standardized conditions
Time frame: At least 2 days
Reproducibility of the transversus abdominis plane block with respect to:
Hillerod Hospital, Denmark
Other
Transversus Abdominis Plane Block: A Placebo-controlled Study in Healthy Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731503
Anesthesia, Local
Montemorelos, Nuevo León, Mexico
View Trial DetailsNCT05320718
Anesthesia, Local, Regional Anesthesia
Beijing, Beijing Municipality, China
View Trial DetailsNCT04846855
Anesthesia, Local, Hematologic Diseases
Quincy-sous-Sénart, IDF, France
View Trial DetailsNCT07672678
Anesthesia, Local, Dental Pulp Diseases
View Trial Details